EP1235795A1 - Verfahren zur herstellung von sulfamiden - Google Patents
Verfahren zur herstellung von sulfamidenInfo
- Publication number
- EP1235795A1 EP1235795A1 EP00976591A EP00976591A EP1235795A1 EP 1235795 A1 EP1235795 A1 EP 1235795A1 EP 00976591 A EP00976591 A EP 00976591A EP 00976591 A EP00976591 A EP 00976591A EP 1235795 A1 EP1235795 A1 EP 1235795A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- optionally substituted
- alkyl
- phenyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/34—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfuric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
Definitions
- This invention relates to a process for producing sulfamides, and to novel intermediates used in the process .
- Sulfamides are conventionally prepared by the use of strongly electrophilic reagents such as sulfamoyl chloride, sulfonyl dichloride, phosphorus oxychloride or phosphorus pentachloride .
- Belgian patent 667.311 discloses a method of making sulfamides employing an N-alkyl sulfamoyl chloride.
- all such reagents involve aggressive synthetic methods, and indeed can be inconvenient or dangerous in their practical, industrial, application.
- the invention provides a process for the production of aryl sulfamides that avoids the use of the above hazardous materials and conditions, and gives a high yield.
- the process of the invention is for the production of an aryl sulfamide having the formula O
- ⁇ - , R ⁇ and R 3 are each hydrogen, alkyl
- R 3 is aryl
- R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each hydrogen, alkyl or aryl, and n is 0 or 1, with an amine of the formula
- the reaction can be carried out at ambient temperature or at the reflux temperature of the solvent in which the reaction is performed, and generally the temperature of the reaction is chosen in the range of from 0» C. to
- a polar, aprotic, solvent is preferred, as, for example, acetonitrile .
- a strong base is required for the reaction to proceed, and examples include triethylamine,
- DBN 5-diazabicyclo [4,3,0] non-5-ene
- TED 4-diazabicyclo [2 , 2 , 2] octane
- an alkyl group can be substituted or unsubstituted, and is preferably C ⁇ _g alkyl, being
- a cycloalkyl group preferably containing from 3 to 9 carbon atoms, and may, for example, be substituted by one to three alkyl groups such as methyl.
- the alkyl group can be substituted by halo, C_ _ Q alkoxy, C_ _g cycloalkyl,
- An aryl group can be, for example, naphthyl or, preferably, phenyl, and can be substituted or unsubstituted.
- a substituted aryl group is substituted with one or more, preferably one to three, substituents selected from, for example, an electron-donating substituent such as, for example, C__4 alkyl, C ] __4
- R ⁇ , R ⁇ and R3 are selected from hydrogen, C ⁇ _ alkyl and optionally substituted phenyl.
- R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are preferably hydrogen, and n is preferably 0. It may, nevertheless, be desirable to employ a terminal moiety
- R 4 to R 9 is alkyl or aryl, for instance, in the preparation of stereoisomers .
- substituent R ⁇ is optionally substituted alkyl or phenyl optionally substituted with an electron- donating substituent, and a preferred process is one for the preparation of a compound of the formula O
- R ⁇ - is alkyl or phenyl optionally substituted
- R ⁇ and R ⁇ are each hydrogen, alkyl or optionally substituted phenyl
- R ⁇ is phenyl optionally substituted with
- an electron-donating substituent and/or R ⁇ is optionally substituted phenyl
- a particularly preferred process is one for the production of a compound of the above formula in which R! is C_ _ Q alkyl or phenyl optionally substituted
- R ⁇ is C ⁇ - alkyl
- R ⁇ is phenyl optionally substituted with
- an electron-donating substituent and/or R ⁇ is optionally substituted phenyl.
- Hal is chloro or bromo
- the sulfamides of formula (I) can be put to many uses, One such is disclosed in EP-A 0 897921, in which a sulfamide is cyclised to produce a benzothiadiazine dioxide intermediate employed in the preparation of pharmaceutically active compounds.
- reaction mixture was filtered and the filter cake washed with water (0.2 L) and dried at 50 «C under reduced pressure to yield 90.82 g (0.355 mol) of crude 2-oxo-oxazolidine-3-sulfonic acid (4-methylphenyl) - amide.
- Triethylamine (3.50 ml, 2.55 g, 25.2 mmol, 2.5 equiv) and tert-amylamine (1.50 ml, 1.12 g, 12.8 mmol, 1.3 equiv) were added to a solution of 2-oxo- oxazolidine-3-sulfonic acid (4-methylphenyl) -amide (2.56 g, 10 mmol, 1.0 equiv) in acetonitrile (12.5 ml). This mixture was heated at reflux for 8 h.
- Triethylamine (7.0 ml, 5.10 g, 50 mmol, 2.5 equiv) and 4-methanesulfonyl-phenylamine ( .28 g, 25 mmol, 1.25 equiv) were added to a solution of 2-oxo-oxazolidine-3- sulfonic acid (4-methylphenyl) -amide (5.12 g, 20 mmol) in acetonitrile (25 ml) . This reaction mixture was heated at reflux for 8 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9927302 | 1999-11-18 | ||
GB9927302A GB2356398A (en) | 1999-11-18 | 1999-11-18 | Preparation of arylsulfamides |
PCT/US2000/028877 WO2001036383A1 (en) | 1999-11-18 | 2000-11-03 | Process for the preparation of sulfamides |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1235795A1 true EP1235795A1 (de) | 2002-09-04 |
Family
ID=10864756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00976591A Withdrawn EP1235795A1 (de) | 1999-11-18 | 2000-11-03 | Verfahren zur herstellung von sulfamiden |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1235795A1 (de) |
JP (1) | JP2003514797A (de) |
AU (1) | AU1434301A (de) |
CA (1) | CA2391978A1 (de) |
GB (1) | GB2356398A (de) |
WO (1) | WO2001036383A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395548A1 (de) | 2001-02-26 | 2004-03-10 | 4Sc Ag | Derivate von diphenylharnstoff, diphenyloxalsäurediamid und diphenylschwefelsäurediamid und ihre verwendung als medikamente |
MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
GB0423554D0 (en) | 2004-10-22 | 2004-11-24 | Cancer Rec Tech Ltd | Therapeutic compounds |
US7951819B2 (en) | 2006-04-26 | 2011-05-31 | Cancer Research Technology Limited | Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
NZ586418A (en) | 2007-12-19 | 2012-09-28 | Cancer Rec Tech Ltd | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
GB0807609D0 (en) | 2008-04-25 | 2008-06-04 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
CN101569864B (zh) * | 2008-04-29 | 2011-08-03 | 中山大学 | 手性磺胺类有机小分子催化剂及其应用 |
WO2011092469A1 (en) | 2010-02-01 | 2011-08-04 | Cancer Research Technology Limited | 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
CN108250121A (zh) * | 2016-12-28 | 2018-07-06 | 上海长森药业有限公司 | 磺酰胺-芳基酰胺类化合物及其治疗乙型肝炎的药物用途 |
-
1999
- 1999-11-18 GB GB9927302A patent/GB2356398A/en not_active Withdrawn
-
2000
- 2000-11-03 AU AU14343/01A patent/AU1434301A/en not_active Abandoned
- 2000-11-03 CA CA002391978A patent/CA2391978A1/en not_active Abandoned
- 2000-11-03 JP JP2001538874A patent/JP2003514797A/ja not_active Withdrawn
- 2000-11-03 WO PCT/US2000/028877 patent/WO2001036383A1/en not_active Application Discontinuation
- 2000-11-03 EP EP00976591A patent/EP1235795A1/de not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO0136383A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001036383A1 (en) | 2001-05-25 |
AU1434301A (en) | 2001-05-30 |
GB9927302D0 (en) | 2000-01-12 |
GB2356398A (en) | 2001-05-23 |
JP2003514797A (ja) | 2003-04-22 |
CA2391978A1 (en) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1735309B1 (de) | Verbesserte verfahren zur herstellung von n-([1,2,4]triazolopyrimidin-2-yl)arylsulfonamiden | |
US20110306772A1 (en) | Process for the preparation of 2-chloro-5-chloromethyl-thiazole | |
HU202184B (en) | Process for producing terc-butyl-3-oxobutirate | |
WO2001036383A1 (en) | Process for the preparation of sulfamides | |
EP0759431B1 (de) | Verfahren zur Herstellung von Sulfonylharnstoffen | |
KR0178542B1 (ko) | 디티오카르밤산의 염류, 그 제조방법 및 그 디티오카르밤산의 염류를 사용하는 이소티오시아네이트류의 제조방법 | |
CA1238921A (en) | 2-ketosulfonamides and process for their preparation | |
KR20030027069A (ko) | 살충제 클로로티아졸의 연속적인 제조 방법 | |
KR100302346B1 (ko) | 6-히드록시-2-옥소-1,2,3,4-테트라히드로퀴놀린의 제조방법 | |
RU2156238C2 (ru) | Способ получения диоксоазабициклогексанов | |
EP0500952B1 (de) | Verfahren zur herstellung eines stickstoffhaltigen heterozyklus | |
US6121476A (en) | Process for preparing dithiocarbonimide derivatives | |
HU189111B (en) | Process for producing thiazol derivatives | |
JP2991832B2 (ja) | ピリミジン誘導体の製造方法 | |
RU2744470C1 (ru) | Способ получения изотиобарбамина | |
EP0010852B1 (de) | Verfahren zur Herstellung von Tetramisol | |
JP2004506634A (ja) | イミダゾピリジン類の製造方法 | |
KR20230135108A (ko) | 2-[2-(2-클로로티아졸-5-일)-2-옥소-에틸]술파닐-6-히드록시-3-메틸-5-페닐-피리미딘-4-온의제조 방법 | |
EP0053038A2 (de) | 3-Amino-2-alkenylimidate, ihre Herstellung und Umwandlung in Zwischenverbindungen für Herbizide | |
JPS60158182A (ja) | 置換されたキナゾリン‐2,4(1h,3h)‐ジオン類の製造方法 | |
JPS62267267A (ja) | ピラゾ−ル誘導体およびその製造法 | |
KR790001653B1 (ko) | S-트리아졸로[3, 4-b] 벤조티아졸류의 제조방법 | |
JP3810820B2 (ja) | オキサジン誘導体の製造方法 | |
JP3896450B2 (ja) | N−置換あるいはn,n−ジ置換スルフェンアミド化合物の製造方法 | |
GB1570912A (en) | Aromatic sulphonamido derivatives and process for their manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020618 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20030530 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20031010 |